Surveillance of SARS-CoV-2 in Healthcare Workers Before and After COVID-19 Vaccination: A Cohort Study in a Primary Care Unit of Brazil.

Ana Cl��udia Pinheiro Torres, Raissa Nogueira de Brito, Wildo Navegantes de Ara��jo, Priscilla Pedrette, Daiani Cristina Cili��o Alves, Ana Izabel Passarella Teixeira, Carolina Carvalho Gontijo, Gustavo Adolfo Sierra Romero, Rodrigo Gurgel-Gon��alves, Walter Massa Ramalho
Author Information
  1. Ana Cl��udia Pinheiro Torres: Center for Tropical Medicine, University of Bras��lia, Bras��lia 70910-900, DF, Brazil.
  2. Raissa Nogueira de Brito: Department of Anthropology, University of Georgia, Athens, GA 30602, USA.
  3. Wildo Navegantes de Ara��jo: Center for Tropical Medicine, University of Bras��lia, Bras��lia 70910-900, DF, Brazil. ORCID
  4. Priscilla Pedrette: Laboratory of Geography, Environment and Health, University of Bras��lia, Bras��lia 70910-900, DF, Brazil. ORCID
  5. Daiani Cristina Cili��o Alves: Laboratory of Molecular Diagnostics of University Hospital-EBSERH, University of Bras��lia, Bras��lia 70910-900, DF, Brazil.
  6. Ana Izabel Passarella Teixeira: Campus Parana��ba, Federal University of Mato Grosso do Sul, Parana��ba 79070-900, MS, Brazil.
  7. Carolina Carvalho Gontijo: Laboratory of Human Genetics, University of Bras��lia, Bras��lia 70910-900, DF, Brazil.
  8. Gustavo Adolfo Sierra Romero: Center for Tropical Medicine, University of Bras��lia, Bras��lia 70910-900, DF, Brazil. ORCID
  9. Rodrigo Gurgel-Gon��alves: Center for Tropical Medicine, University of Bras��lia, Bras��lia 70910-900, DF, Brazil. ORCID
  10. Walter Massa Ramalho: Center for Tropical Medicine, University of Bras��lia, Bras��lia 70910-900, DF, Brazil. ORCID

Abstract

INTRODUCTION: Healthcare workers (HCWs) are at higher risk of SARS-CoV-2 infection. Viral surveillance for early detection of COVID-19 is a critical strategy to understand this population's infection dynamics and prevent transmission. The study examines SARS-CoV-2 infection and reinfection among HCWs vaccinated against COVID-19 working at a primary healthcare unit serving a disenfranchised community in Brazil.
METHODS: The study was conducted in Cidade Estrutural, Federal District, Brazil, between February and October 2021. Participants were interviewed and provided samples. A prospective open cohort study was used to analyze the frequency of SARS-CoV-2 infection and reinfection, and the vaccine-induced seroconversion. Nasopharyngeal swab specimen was collected from workers presenting with flu-like symptoms and subjected to RT-qPCR. Peripheral blood samples were also collected every 30 �� 2 days for eight months, starting from the day Participants received their first dose of COVID-19 vaccine, and submitted to serological testing (IgM and IgG chemiluminescence). The frequencies of infection and reinfection (RT-qPCR positive results 90 days after the infection) were calculated along with their respective confidence intervals (95% CI).
RESULTS: Of the 128 workers, 61 (47.65%; CI: 39.19-56.25) reported probable SARS-CoV-2 infection before vaccination and 50 (39.06%; CI: 31.04-47.71) had SARS-CoV-2 infection after vaccination, confirmed by molecular test. Reinfection was identified in seven workers (7/50, 14%; CI: 6.95-26.18) based on the 90-day interval between results. The serological data from the 128 workers during the cohort indicated that 68 (53.12%; CI: 44.5-61.5) had IgG antibodies and 46 had IgM antibodies (35.93%; CI: 28.14-44.54) against SARS-CoV-2. SARS-CoV-2 infection was common in 56% of the community health workers (CHWs), 50% of registered nurses, and licensed vocational nurses (33%). Following the COVID-19 vaccination, the percentage of infections among HCWs decreased from 47.83% to 4.35%.
CONCLUSION: These results demonstrate that (i) approximately 40% of the workers were infected with SARS-CoV-2 in 2021 and (ii) reinfections confirmed by RT-qPCR occurred in 14% of the HCWs after vaccination. The results provide valuable insights into the circulation of SARS-CoV-2 among HCWs in a primary care unit serving a minoritized community.

Keywords

References

  1. BMC Public Health. 2019 May 16;19(1):581 [PMID: 31096940]
  2. BMJ Open. 2024 Apr 5;14(4):e079776 [PMID: 38582533]
  3. Vaccines (Basel). 2023 Apr 28;11(5): [PMID: 37243020]
  4. Epidemiol Infect. 2023 Mar 20;151:e52 [PMID: 36938809]
  5. Int J Infect Dis. 2021 Aug;109:283-285 [PMID: 34271203]
  6. Braz J Microbiol. 2023 Jun;54(2):859-871 [PMID: 37052752]
  7. Viruses. 2023 Apr 17;15(4): [PMID: 37112964]
  8. Annu Rev Public Health. 2022 Apr 5;43:311-330 [PMID: 34995130]
  9. Healthcare (Basel). 2022 May 12;10(5): [PMID: 35628032]
  10. Waste Manag. 2019 Nov;99:71-78 [PMID: 31473483]
  11. J Clin Lab Anal. 2020 Oct;34(10):e23466 [PMID: 32671890]
  12. BMC Infect Dis. 2020 Dec 2;20(1):917 [PMID: 33267836]
  13. BMJ Open. 2023 May 2;13(5):e068996 [PMID: 37130692]
  14. Am J Infect Control. 2023 Mar;51(3):248-254 [PMID: 36375707]
  15. Sci Rep. 2024 Mar 5;14(1):5418 [PMID: 38443618]
  16. Occup Med (Lond). 2024 Feb 19;74(1):71-77 [PMID: 37995321]
  17. Emerg Infect Dis. 2021 Apr;27(4):1220-1222 [PMID: 33522478]
  18. Cochrane Database Syst Rev. 2022 May 6;5:CD015112 [PMID: 35514111]
  19. PeerJ. 2023 Apr 11;11:e15024 [PMID: 37065688]
  20. J Med Virol. 2022 May;94(5):2139-2148 [PMID: 35060174]
  21. Antimicrob Steward Healthc Epidemiol. 2022 Dec 01;2(1):e188 [PMID: 36505945]
  22. Healthcare (Basel). 2022 Oct 20;10(10): [PMID: 36292544]
  23. AIMS Public Health. 2023 Jul 21;10(3):593-609 [PMID: 37842272]
  24. J Glob Health. 2020 Jun;10(1):010379 [PMID: 32582441]
  25. Emerg Infect Dis. 2022 Oct;28(13):S238-S243 [PMID: 36502444]
  26. Viruses. 2023 Jul 14;15(7): [PMID: 37515237]

Grants

  1. 00193-00000495/2020-72/Funda����o de Amparo �� Pesquisa do Distrito Federal (FAP-DF, http://www.fap.df.gov.br)
  2. 23106.028855/2020-74/Ministru of Education (MEC, http://portal.mec.gov.br)

Word Cloud

Created with Highcharts 10.0.0SARS-CoV-2infectionworkersCOVID-19HCWsCI:resultsvaccinationstudyreinfectionamongcommunityBrazilRT-qPCRHealthcareprimaryunitserving2021samplescohortcollecteddaysserologicalIgMIgG1284739confirmed14%antibodiesnursesINTRODUCTION:higherriskViralsurveillanceearlydetectioncriticalstrategyunderstandpopulation'sdynamicspreventtransmissionexaminesvaccinatedworkinghealthcaredisenfranchisedMETHODS:conductedCidadeEstruturalFederalDistrictFebruaryOctoberParticipantsinterviewedprovidedprospectiveopenusedanalyzefrequencyvaccine-inducedseroconversionNasopharyngealswabspecimenpresentingflu-likesymptomssubjectedPeripheralbloodalsoevery30��2eightmonthsstartingdayparticipantsreceivedfirstdosevaccinesubmittedtestingchemiluminescencefrequenciespositive90calculatedalongrespectiveconfidenceintervals95%CIRESULTS:6165%19-5625reportedprobable5006%3104-4771moleculartestReinfectionidentifiedseven7/50695-2618based90-dayintervaldataindicated685312%445-615463593%2814-4454common56%healthCHWs50%registeredlicensedvocational33%Followingpercentageinfectionsdecreased83%435%CONCLUSION:demonstrateapproximately40%infectediireinfectionsoccurredprovidevaluableinsightscirculationcareminoritizedSurveillanceWorkersVaccination:CohortStudyPrimaryCareUnitmonitoringseroprevalence

Similar Articles

Cited By

No available data.